The DOI matches its Crossref record.
Poly(alkyl cyanoacrylate) Nanospheres for Oral Administration of Insulin
Abstract
Poly(alkyl cyanoacrylate) nanocapsules have been successfully used for oral administration of insulin in diabetic rats. This work reports a suitable formulation for insulin-loaded nanospheres composed of full polymeric structures formed by polymerization of isobutyl cyanoacrylate (IBCA) in an acidic medium, insulin (15 U/mL) being added to the polymerization medium 60 min after the onset of polymerization. These nanospheres (MW 364) displayed a mean size of 145 nm and an association rate of 1 U of insulin/mg of polymer. They protected insulin from the degradation by proteolytic enzymes in vitro, especially when they were dispersed in an oily medium (Miglyol 812) containing surfactive agents (Poloxamer 188 and deoxycholic acid). When dispersed in the same medium, insulin-loaded nanospheres (100 U/kg of body weight), administered perorally in streptozotocin-induced diabetic rats, provoked a 50% decrease of fasted glycemia from the second hour up to 10-13 days. This effect was shorter (2 days) or absent when nanospheres were dispersed in water with surfactive agents or not. Using 14C-labeled nanospheres loaded with [125I]insulin, it was found that nanospheres increased the uptake of [125I]insulin or its metabolites in the gastrointestinal tract, blood, and liver while the excretion was delayed when compared to [125I]insulin nonassociated to nanospheres; in addition, 14C- and 125I-radioactivities disappeared progressively as a function of time, parallel to the biological effect. Thus insulin-loaded nanospheres can be considered as a convenient delivery system for oral insulin at the prerequisite that they were dispersed in an oily phase containing surfactants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Self-citationAlginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 527
Self-citationSonavane, G., Tomoda, K., Sano, A., Ohshima, H., Terada, H., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.02.013 · Cited by 383
Prevention of toxic epidermal necrolysis by regulatory T cells
Azukizawa, H., Sano, S., Kosaka, H., Sumikawa, Y., & Itami, S. (2005) · European Journal of Immunology · doi:10.1002/eji.200425773 · Cited by 380
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats
Damgé, C., Maincent, P., & Ubrich, N. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.023 · Cited by 351
Self-citationColloidal drug carriers: achievements and perspectives
Barratt, G. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180300002 · Cited by 333
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles
Vrignaud, S., Benoit, J.-P., & Saulnier, P. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.057 · Cited by 309
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin
Pardakhty, A., Varshosaz, J., & Rouholamini, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.002 · Cited by 292
Therapeutic applications of colloidal drug carriers
Barratt, G. M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00255-8 · Cited by 282
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Metadata
- Authors
- Damgé, C., Vranckx, H., Balschmidt, P., & Couvreur, P.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- American Geophysical Union (AGU)
- Published
- 1997-12
- Volume
- 86
- Issue
- 12
- Pages
- 1403-1409
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2109835762
- Cited by
- 178
- References
- 0
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.